Özlem KUMBASAR ÖZDEMİR, Orhan KÜÇÜKŞAHİN, Özlem DİKEN ERÇEN, Aydın ÇİLEDAĞ

Miyozitsiz antisentetaz sendromunda pulmoner arteryel hipertansiyon

Pulmonary arterial hypertension in antisynthetase syndrome without myositis

PDF

___

1.Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007; 19: 523-9.
2.Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 2011; 37: 100-9.
3.Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 2010; 138: 1464-74.
4.Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short term and long term outcome of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011; 63: 3439-47.
5.Taniguchi Y, Horino T, Kato T, Terada Y. Acute pulmonary arterial hypertension associated with anti-synthetase syndrome. Scand J Rheumatol 2010; 39: 179-80.
6.Taniguchi Y, Horino T, Kato T, Terada Y. Acute pulmonary arterial hypertension associated with anti-synthetase syndrome. Scand J Rheumatol 2010; 39: 179-80.
7.Patel HC, Lauder NN. The Antisynthetase Syndrome. Am J Med 2011; 124: e3-4.
8.Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelapis GE. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis. Clin Rheum 2007; 26: 108-11.
9.Phillips TJ, Leigh IM, Wright J. Dermatomyositis and pulmonary fibrosis associated with anti-Jo-1 antibody. Acad Dermatol 1987; 17: 381-2.
10.Chatterjee S, Farver C. Severe pulmonary hypertension in Anti-Jo-1 syndrome. Arthritis Care Res 2010; 62: 425-9.
11.Cavagna L, Prisco E, Montecucco C, Caporali R. Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. Arthritis Care Res 2011; 63: 63-4.
12.Marie I, Dominique S, Janvresse A, Levesque H, Menard JF. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med 2012;[Epub ahead of print.]
13.Ball EM, Savage EM, Pendleton A. Refractory anti-synthetase syndrome treated with rituximab. Rheumatology (Oxford) 2010; 49: 1013.